Lilly Bussmann

Head of Strategic Capital at Oxford Science Enterprises

Head of Strategic Capital
2021 - Current
Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational companies via its unique partnership with Oxford University, the world’s #1 research university. From company formation, seed to Series C+. OSE's portfolio covers deep tech, health tech and biotech. Past investments include: Base Genomics (Exact Sciences) Yasa Motors (Mercedes) LatentLogic (Waymo) PepGen (Nasdaq) Barinthus (Nasdaq) Semantic Technologies (Samsung)

Partner
2020 - 2021
www.rtpartners.co Oxford Nanopore (LON:ONT) E-Therapeutics (LON:ETX) CoMind